The two-site assay illustrates regions of coincidence between HIF1β/HIF2α in the control cancer adjacent normal kidney tissue (B7) and two additional ccRCC samples A5 and B5. This evidence concerns the gene EPAS1 and nonpapillary renal cell carcinoma.